A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase II Study of Subcutaneously Administered Interferon Beta 1a in the Treatment of Patiens with Aktive Rheumatoid Arthritis | Charles Explorer

A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase II Study of Subcutaneously Administered Interferon Beta 1a in the Treatment of Patiens with Aktive Rheumatoid Arthritis

Publikace

Abstrakt

Subcutaneously Administered Interferon Beta 1, Aktive Rheumatoid Arthritis

Osoby